Poltreg S.A.

zł 19.20As of Sun 8 Nov 2026, 12:00 UTC
WSE:PTGHealthcare
Country Poland
PE (Fwd) •••
TSR 5Y CAGR (20.33%)
Div yield —
ROE (46.98%)
Biotechnology
Beta (5Y) 0.77
PE TTM —
TSR TTM (24.71%)
Mkt cap zł 113.6M
ROIC (25.29%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
zł 24
22.74%
(23.40%)
Hold 1|12|7|6|3
4Q25
1Q26
2Q26
3Q26
Earnings per sharezł
0.22
0.21
0.23
0.24
25.91%
7.88%
8.36%
18.55%
Revenuezł M
8.393
8.420
8.172
8.529
10.95%
9.73%
3.10%
3.40%
Peers (US$28.69M)
Cap (US$)
PE
31.51M
—
28.93M
—
24.17M
—
Capital
TTM
5Y
10Y
Leveragex
8.826
0.118
0.110
EBIT/Intx
0.321
0.296
0.241
Own earn%
135.05
(45.30)
(38.24)
Sh yield%
51.92
32.81
33.35
Owners
Insiders/Inst%
12.07
29.34
Short interest%
5.82
SBC / revenue%
2.56
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
25–32
$1 testx
—
Incr. ROIC%
12